Corporate information
Registration country
Company type
Innate immune drug development companyFunding rounds
Series C EUR 33,000,000
( )
Participants: BB Biotech Ventures (co-led the round), existing investor Novartis Venture Fund (co-led the round), Sunstone Capital, Baxter Ventures, Amgen Ventures, EMBL Ventures, existing investors Fountain Healthcare Partners, Roche Venture Fund, Seroba
Investor | Profile | Country | |
---|---|---|---|
Amgen Ventures | |||
Baxter Ventures | |||
BB Biotech Ventures | |||
EMBL Ventures GmbH (EMBL Venture Capital) | |||
Fountain Healthcare Partners | |||
Novartis Venture Funds | The corporate venturing arm of Novartis. | ||
Roche Venture Fund | The corporate venture fund of the healthcare company Roche | ||
Seroba Kernel Life Sciences Ltd | |||
Sunstone Capital AS |
Investment activity status
Active investor